IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients. - Sim GC; Martin-Orozco N; Jin L; Yang Y; Wu S; Washington E; Sanders D; Lacey C; Wang Y; Vence L; Hwu P; Radvanyi L (The Journal of clinical investigation, 2014)